Influenza vaccination and the evolution of evidence-based recommendations for older adults: A Canadian perspective

Melissa K. Andrew; Shelly A. McNeil

doi:10.1016/j.vaccine.2020.09.011

Influenza vaccination and the evolution of evidence-based recommendations for older adults: A Canadian perspective

Melissa K. Andrew, Shelly A. McNeil

Medicine

Résultat de recherche: Review article › examen par les pairs

5 Citations (Scopus)

Résumé

Older adults are at high risk from influenza and its complications, and are therefore an important population for prevention efforts. In Canada, public health efforts targeting influenza are multi-pronged and include vaccination programs as well as surveillance which informs the national surveillance reporting platform FluWatch run by the Public Health Agency of Canada. Recommendations regarding use of vaccines are made nationally by the National Advisory Committee on Immunization (NACI) and by the Comité sur l'immunisation du Québec in Quebec, while vaccination programs are planned and delivered at the provincial/territorial level as opposed to as a harmonized national immunization program. NACI performs rigorous targeted literature reviews to inform their statements, and recommendations also vary by whether they apply on Individual (pertaining to decisions for individual patients) vs. Programmatic (informing policy decisions for implementation of publicly funded vaccination programs) levels. This unique context results in inter-provincial variation in vaccine schedules and funded vaccine products. In this paper, the importance of influenza vaccination for older adults is discussed; to provide insights from the Canadian context, the evolution of NACI evidence reviews and recommendations on influenza vaccination is presented.

Langue d'origine	English
Pages (de-à)	A36-A41
Journal	Vaccine
Volume	39
DOI	https://doi.org/10.1016/j.vaccine.2020.09.011
Statut de publication	Published - mars 15 2021

Note bibliographique

Funding Information:
The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: No funding or payment was involved in the preparation of this review. MKA and SAM report grant funding from the Public Health Agency of Canada through Service Canada, Canadian Institutes of Health Research, and Canadian Immunization Research Network in the conduct of the Serious Outcomes Surveillance Network. MKA reports grant funding from the Canadian Frailty Network, Sanofi, GSK, and Pfizer, and payments from Sanofi and Pfizer outside the submitted work. SAM reports grant and clinical trials funding from GSK, Merck, Pfizer and Sanofi, and payments from GSK, Pfizer, Sanofi and Merck outside the submitted work.

Publisher Copyright:
© 2020 The Author(s)

ASJC Scopus Subject Areas

Molecular Medicine
General Immunology and Microbiology
General Veterinary
Public Health, Environmental and Occupational Health
Infectious Diseases

PubMed: MeSH publication types

Journal Article
Research Support, Non-U.S. Gov't
Review

ODD de l’ONU

Cette action contribue à la réalisation des objectifs de développement durable suivants

Accès au document

10.1016/j.vaccine.2020.09.011

Autres fichiers et liens

Citer

@article{1f13b99426e340968aa45bd12800b33e,

title = "Influenza vaccination and the evolution of evidence-based recommendations for older adults: A Canadian perspective",

abstract = "Older adults are at high risk from influenza and its complications, and are therefore an important population for prevention efforts. In Canada, public health efforts targeting influenza are multi-pronged and include vaccination programs as well as surveillance which informs the national surveillance reporting platform FluWatch run by the Public Health Agency of Canada. Recommendations regarding use of vaccines are made nationally by the National Advisory Committee on Immunization (NACI) and by the Comit{\'e} sur l'immunisation du Qu{\'e}bec in Quebec, while vaccination programs are planned and delivered at the provincial/territorial level as opposed to as a harmonized national immunization program. NACI performs rigorous targeted literature reviews to inform their statements, and recommendations also vary by whether they apply on Individual (pertaining to decisions for individual patients) vs. Programmatic (informing policy decisions for implementation of publicly funded vaccination programs) levels. This unique context results in inter-provincial variation in vaccine schedules and funded vaccine products. In this paper, the importance of influenza vaccination for older adults is discussed; to provide insights from the Canadian context, the evolution of NACI evidence reviews and recommendations on influenza vaccination is presented.",

author = "Andrew, {Melissa K.} and McNeil, {Shelly A.}",

note = "Funding Information: The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: No funding or payment was involved in the preparation of this review. MKA and SAM report grant funding from the Public Health Agency of Canada through Service Canada, Canadian Institutes of Health Research, and Canadian Immunization Research Network in the conduct of the Serious Outcomes Surveillance Network. MKA reports grant funding from the Canadian Frailty Network, Sanofi, GSK, and Pfizer, and payments from Sanofi and Pfizer outside the submitted work. SAM reports grant and clinical trials funding from GSK, Merck, Pfizer and Sanofi, and payments from GSK, Pfizer, Sanofi and Merck outside the submitted work. Publisher Copyright: {\textcopyright} 2020 The Author(s)",

year = "2021",

month = mar,

day = "15",

doi = "10.1016/j.vaccine.2020.09.011",

language = "English",

volume = "39",

pages = "A36--A41",

journal = "Vaccine",

issn = "0264-410X",

publisher = "Elsevier BV",

}

TY - JOUR

T1 - Influenza vaccination and the evolution of evidence-based recommendations for older adults

T2 - A Canadian perspective

AU - Andrew, Melissa K.

AU - McNeil, Shelly A.

N1 - Funding Information: The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: No funding or payment was involved in the preparation of this review. MKA and SAM report grant funding from the Public Health Agency of Canada through Service Canada, Canadian Institutes of Health Research, and Canadian Immunization Research Network in the conduct of the Serious Outcomes Surveillance Network. MKA reports grant funding from the Canadian Frailty Network, Sanofi, GSK, and Pfizer, and payments from Sanofi and Pfizer outside the submitted work. SAM reports grant and clinical trials funding from GSK, Merck, Pfizer and Sanofi, and payments from GSK, Pfizer, Sanofi and Merck outside the submitted work. Publisher Copyright: © 2020 The Author(s)

PY - 2021/3/15

Y1 - 2021/3/15

N2 - Older adults are at high risk from influenza and its complications, and are therefore an important population for prevention efforts. In Canada, public health efforts targeting influenza are multi-pronged and include vaccination programs as well as surveillance which informs the national surveillance reporting platform FluWatch run by the Public Health Agency of Canada. Recommendations regarding use of vaccines are made nationally by the National Advisory Committee on Immunization (NACI) and by the Comité sur l'immunisation du Québec in Quebec, while vaccination programs are planned and delivered at the provincial/territorial level as opposed to as a harmonized national immunization program. NACI performs rigorous targeted literature reviews to inform their statements, and recommendations also vary by whether they apply on Individual (pertaining to decisions for individual patients) vs. Programmatic (informing policy decisions for implementation of publicly funded vaccination programs) levels. This unique context results in inter-provincial variation in vaccine schedules and funded vaccine products. In this paper, the importance of influenza vaccination for older adults is discussed; to provide insights from the Canadian context, the evolution of NACI evidence reviews and recommendations on influenza vaccination is presented.

AB - Older adults are at high risk from influenza and its complications, and are therefore an important population for prevention efforts. In Canada, public health efforts targeting influenza are multi-pronged and include vaccination programs as well as surveillance which informs the national surveillance reporting platform FluWatch run by the Public Health Agency of Canada. Recommendations regarding use of vaccines are made nationally by the National Advisory Committee on Immunization (NACI) and by the Comité sur l'immunisation du Québec in Quebec, while vaccination programs are planned and delivered at the provincial/territorial level as opposed to as a harmonized national immunization program. NACI performs rigorous targeted literature reviews to inform their statements, and recommendations also vary by whether they apply on Individual (pertaining to decisions for individual patients) vs. Programmatic (informing policy decisions for implementation of publicly funded vaccination programs) levels. This unique context results in inter-provincial variation in vaccine schedules and funded vaccine products. In this paper, the importance of influenza vaccination for older adults is discussed; to provide insights from the Canadian context, the evolution of NACI evidence reviews and recommendations on influenza vaccination is presented.

UR - http://www.scopus.com/inward/record.url?scp=85091203731&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85091203731&partnerID=8YFLogxK

U2 - 10.1016/j.vaccine.2020.09.011

DO - 10.1016/j.vaccine.2020.09.011

M3 - Review article

C2 - 32958335

AN - SCOPUS:85091203731

SN - 0264-410X

VL - 39

SP - A36-A41

JO - Vaccine

JF - Vaccine

ER -

Influenza vaccination and the evolution of evidence-based recommendations for older adults: A Canadian perspective

Résumé

Note bibliographique

ASJC Scopus Subject Areas

PubMed: MeSH publication types

ODD de l’ONU

Accès au document

Autres fichiers et liens

Empreinte numérique

Citer